FORT DETRICK, Md. – Researchers on the Defense Health Agency Research & Development-Medical Research and Development Command’s Medical Research Institute of Chemical Defense have developed a brand new mannequin for testing nerve agent publicity and drug efficacy that extra precisely replicates human responses to poisonous substances. The mannequin, developed with funding from the Joint Science and Technology Office for Chemical and Biological Defense, Chemical and Biological Technologies Department, Research and Development Directorate, Defense Threat Reduction Agency (JSTO CBDP, RD-DTRA), is already being utilized in research that would result in the fielding of the subsequent technology of nerve agent countermeasures – guaranteeing improved Warfighter survivability, resiliency, and lethality in chemically contaminated environments.
The new testing methodology, developed by analysis chemist Dr. C. Linn Cadieux and her group at USAMRICD’s Medical Toxicology Research Division, makes it doable to conduct exact “apples-to-apples” comparisons of various countermeasures to evaluate their efficacy extra exactly than earlier than.
“This method provides decisionmakers with an easy to understand comparison table that can be used to identify how well a given countermeasure works against a given nerve agent,” says Cadieux. “That kind of information is very helpful for making decisions about which new countermeasures to field.”
Nerve brokers work by interfering with {the electrical} indicators that trigger muscle tissue to contract and loosen up. In a wholesome nervous system, an enzyme referred to as acetylcholinesterase – or AChE for brief –modulates these electrical indicators. Nerve brokers stop AChE from finishing up that very important perform, inflicting muscle tissue to stay paralyzed – probably inflicting everlasting harm to very important organs and, in extreme circumstances, demise by asphyxiation or cardiac arrest.
The mannequin developed by Cadieux with fellow analysis chemists Dr. Nicholas Paparoidamis and Dr. Robert diTargiani, makes use of human AChE to imitate how a wholesome individual responds to nerve agent publicity and life-saving medical remedies extra precisely than different laboratory fashions presently in use. It guarantees to permit researchers to display candidate medicine far more rapidly than presently doable, probably rushing up the method of fielding new lifesaving countermeasures to guard Warfighters.
DISTRIBUTION STATEMENT A. Approved for Public Release
In addition to offering safety towards nerve brokers, the brand new mannequin additionally reveals promise in aiding within the improvement of therapies for different neurodegenerative issues by which AChE performs a job, together with Alzheimer’s illness and dementia. In half due to her work on this challenge, Cadieux acquired a 2024 Presidential Early Career Award for Scientists and Engineers. Administered by the National Science and Technology Council, PECASE is the federal authorities’s highest honor for excellent early profession scientists and engineers.
DTRA approached Cadieux to undertake the examine in 2020 as a comply with-on to a earlier profitable examine that her group had carried out for JSTO. While the COVID pandemic – which started shortly after the challenge began – required the group to cut back the extent of worldwide participation that had initially been envisioned, the group was nonetheless in a position to incorporate suggestions from the worldwide companions and hold the momentum going. They additionally collaborated carefully with researchers all through a number of workplaces inside USAMRICD, drawing on their experience to make sure the work adhered to the rigorous requirements of the Good Laboratory Practice regulatory framework, which will likely be essential if the medicine are submitted to the U.S. Food and Drug Administration for evaluation. As a end result, the group was in a position to efficiently consider the effectiveness of 4 completely different nerve agent countermeasures utilizing the brand new mannequin.
JSTO plans to include the outcomes of the examine into its predictive device for chemical and organic operational well being results referred to as FXCODA. This device will use the info to estimate potential human well being impacts ensuing from nerve agent incidents over time. This data will, in flip, inform the choice of the subsequent technology of medical countermeasures.
Cadieux says the contributions of Paparoidamis and diTargiani and their groups to the success of the challenge are an instance of how USAMRICD’s tradition of encouraging collaboration and innovation results in sport-altering outcomes.
“This project allowed me to work with a great team that took my crazy idea and brought it all the way to fruition and create something that will help save Warfighters’ lives,” Cadieux mentioned. “It also makes us very happy to know how useful this work is going to be across so many different fields. That’s why we do what we do.”